Egyptian International Pharmaceutical Industries Company stock joins S&P index

Published on 09/29/2026 at 21:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Egyptian International Pharmaceutical Industries Company stock joined the S&P Pan Arab Composite on September 21, 2026. Fiscal 2025 revenue rose 24.38 percent.

PHAR, EGS38081C013, Illustration mit AI erstellt.

Egyptian International Pharmaceutical Industries Company (ISIN EGS38081C013) joined the S&P Pan Arab Composite on September 21, 2026, according to MarketScreener. The index change gives PHAR a fresh benchmark connection as the Egyptian pharmaceutical company continues to expand products and exports.

Index inclusion adds visibility

The same MarketScreener entry also listed PHAR's addition to the S&P Global BMI Index on September 21, 2026. The company profile identifies the business as a manufacturer and marketer of pharmaceutical products, including antibiotics, vitamins, analgesics, ophthalmic medicines and cardiovascular treatments.

Egyptian International Pharmaceutical Industries Company reported fiscal 2025 revenue of EGP 9,441.38 million, compared with EGP 7,590.55 million in fiscal 2024, according to Investing.com. That 24.38 percent increase provides the clearest quantified operating comparison in the latest full-year data.

Profit growth outpaced revenue

Fiscal 2025 net income reached EGP 1,441.66 million, up from EGP 1,095.72 million in fiscal 2024, while operating income increased to EGP 2,341.02 million from EGP 1,506.99 million, the same financial summary shows. Net income growth of 31.57 percent exceeded revenue growth, pointing to stronger earnings conversion during the reported year.

The company's own website lists more than 400 products, 117 pipeline products and 5,000 employees. It also states that EIPICO exports to 78 countries and holds a 24 percent share of Egypt's pharmaceutical exports by value, according to the company information at EIPICO. Those operating metrics make international distribution and product breadth important reference points for the index-linked stock.

PHAR remains below its yearly high

On EGX, PHAR was quoted at EGP 105.60 on September 28, 2026, down 1.31 percent from the prior close. Investing.com listed the 52-week range at EGP 65.00 to EGP 178.99 on the same date, leaving the share price 40.97 percent below the yearly high.